French Hospital Starts Program to Fight Antibiotic Resistance

To address the growing problem of antibiotic resistance, researchers are turning to bacteriophages, which kill bacteria effectively without affecting human cells.

Related Keywords

Georgia ,United States ,Poland ,Russia ,France ,French ,Pherecydes Pharma ,Claude Bernard Lyon ,Charlotte Brives ,French National Reference Center ,Health Products Safety ,Scientific Research ,International Center ,French National Research Agency ,Institute Of Infectious Agents In Lyon ,French National Center ,National Agency For Medicines ,Bacteriology Department ,Infectious Diseases Research ,Durkheim Center ,Reference Center ,Lyon Civilian Hospitals ,French National Research ,Infectious Agents ,Medscape Medical ,Western Europe ,Western European ,Complex Osteoarticular Infections ,French Pharmacopoeia ,European Pharmacopoeia ,National Agency ,Antibiotic Resistance ,Tristan Ferry ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Bacteria ,Escherichia Coli ,Scherichia Coli Infection ,E Coli ,E Coli Infection ,Europe ,European ,Clinical Research ,Clinical Trials ,Linical Studies ,Hospitals ,Inpatient Care ,Antibiotics ,Igecycline ,Healthcare Technology ,Ealth Care Technology ,Medical Innovations ,